secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2025-03-13T23:59:59+00:00
Accession:  0001193125-25-053978
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus prices upsized $125M public offering of 2.8M shares at $44.50/share
--------------------------------------------------------------------------

- Offering of 2,808,988 shares at public price $44.50; net proceeds ~$117.1M.
- Upsized from originally proposed $100M; underwriters have 30-day option for additional 421,348 shares.
- Closing expected March 14, 2025; Goldman Sachs, BofA, Barclays, Oppenheimer lead.
- Offering made under effective shelf registration; use of proceeds not specified in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000119312525053978/0001193125-25-053978-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000119312525053978/d901047d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-053978

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer